Bortezomib does not adversely affect stem cell mobilization...

Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

G.L. Uy, N.M. Fisher, S.M. Devine, D.R. Adkins, M.H. Tomasson, T.A. Graubert, J.F. DiPersio, R. Vij
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2005
Language:
english
DOI:
10.1016/j.bbmt.2004.12.228
File:
PDF, 59 KB
english, 2005
Conversion to is in progress
Conversion to is failed